Back to LYEL

GSA CAPITAL PARTNERS LLP → LYEL

GSA CAPITAL PARTNERS LLP LYEL Position History

Lyell Immunopharma, Inc. • Healthcare

Quarters held
2
Latest value
$376K
Q3 2026
Peak value
$376K
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$368K
Q3 2026$376K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$376K38.4K——
Q2 2026$368K26.2K——

Other funds holding LYEL

Other GSA CAPITAL PARTNERS LLP positions

VGES

VANGUARD SCOTTSDALE FDS

$44.4M
VGES

VANGUARD SCOTTSDALE FDS

$36.1M
VGES

VANGUARD SCOTTSDALE FDS

$32.3M
BLK

ISHARES TR

$28M
VGES

VANGUARD SCOTTSDALE FDS

$25.5M
ETHA

ISHARES TR

$22.8M
ETHA

ISHARES TR

$19.8M
ETHA

ISHARES TR

$16.4M